Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-21-002700

Options or other derivatives

  • Director acquired 204,041 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gayko Urte · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-03 Grant or award : show line 1 in the form Stock Option (right to buy) +200,000 200,000 D
2021-11-03 Grant or award : show line 2 in the form Stock Option (right to buy) +4,041 204,041 D
Loading xslF345X03/form412566001_11162021.xml…